Mantell Joanne E, Myer Landon, Carballo-Diéguez Alex, Stein Zena, Ramjee Gita, Morar Neetha S, Harrison Polly F
HIV Center for Clinical & Behavioral Studies, at the New York State Psychiatric Institute and Columbia University, 1051 Riverside Drive, Unit 15, New York, NY 10032, USA.
Soc Sci Med. 2005 Jan;60(2):319-30. doi: 10.1016/j.socscimed.2004.05.011.
With growing recognition of the potential value of microbicides for HIV/STI prevention, the importance of the acceptability of this brand-new technology has been widely acknowledged. We review the current body of microbicide acceptability research, characterize the limitations in assessment approaches, and suggest strategies for improvement. Electronic databases and abstracts of recent meetings were searched for acceptability data regarding vaginal and rectal products that may be used for HIV prevention. Of the 61 studies reviewed, more than half assessed acceptability based primarily on the description of a hypothetical microbicide, or with the demonstration of a spermicide or lubricant. Physical characteristics of microbicidal products, their effects after insertion, and their effects on sensation during intercourse (for both partners) were the dimensions most frequently assessed (measured in 77%, 49% and 49% of studies, respectively). Attention to the social context of use was inadequate. As acceptability is likely to be a key determinant in the use-effectiveness of microbicides, in-depth understanding of the social processes that shape microbicide acceptability across diverse populations will become increasingly valuable. This includes exploring the effects that sexual partners, health care providers, and key opinion leaders have on the acceptability of microbicides among women and men, including youth and people living with HIV. Future research will benefit from studies of the acceptability of other contraceptive-barrier methods (especially the female condom), use of an agreed-upon operationalization of acceptability, use of acceptability assessments within clinical trials, expansion of measurement domains, and assessment of changes in perceptions of acceptability and use over time. Failure to understand the key factors associated with microbicide acceptability is likely to hinder the adoption and continued use of products that are effective in preventing HIV infection.
随着人们越来越认识到杀微生物剂在预防艾滋病毒/性传播感染方面的潜在价值,这项全新技术的可接受性的重要性已得到广泛认可。我们回顾了当前关于杀微生物剂可接受性的研究,阐述了评估方法中的局限性,并提出了改进策略。我们检索了电子数据库和近期会议的摘要,以获取有关可用于预防艾滋病毒的阴道和直肠产品的可接受性数据。在所审查的61项研究中,超过一半主要基于对一种假设的杀微生物剂的描述,或通过展示一种杀精剂或润滑剂来评估可接受性。杀微生物产品的物理特性、插入后的效果以及对性交过程中(对双方)感觉的影响是最常评估的方面(分别在77%、49%和49%的研究中进行了测量)。对使用的社会背景关注不足。由于可接受性可能是杀微生物剂使用效果的关键决定因素,深入了解影响不同人群杀微生物剂可接受性的社会过程将变得越来越有价值。这包括探索性伴侣、医疗保健提供者和关键意见领袖对男女(包括年轻人和艾滋病毒感染者)杀微生物剂可接受性的影响。未来的研究将受益于对其他避孕屏障方法(尤其是女用避孕套)可接受性的研究、采用商定的可接受性操作化定义、在临床试验中进行可接受性评估、扩大测量领域以及评估随时间推移可接受性和使用观念的变化。未能理解与杀微生物剂可接受性相关的关键因素可能会阻碍有效预防艾滋病毒感染的产品的采用和持续使用。